**Specifications Table**TableSubject area*Biology*More specific subject area*Microbiology*Type of data*Table and figure*How data was acquiredLIS and HIS of *the* hospitalData formatRaw and analyzed dataExperimental factorsAnticoagulant Peripheral blood with heparin LithiumExperimental features*IGRA-ELISA* and ELISPOT testsData source locationXi'an, Shaanxi Province, Northwest China.Data accessibilityData in the article can be accessible through LIS and HIS of *the* hospital

**Value of the data**•This work shows the excellent consistency between T-SPOT.*TB* and IGRA-ELISA for diagnosing *Mycobacterium tuberculosis* infection.•Data in this work demonstrates both T-SPOT.*TB* test and IGRA-ELISA can be used to rule out active TB.•Data in this work indicates that the value change trend of the IGRA-ELISA was consistent with that of T-SPOT.TB test for the positive samples.

1. Data {#s0005}
=======

1.1. The performance of the two tests for diagnostic active TB {#s0010}
--------------------------------------------------------------

The sensitivity and specificity for diagnostic active TB using T-SPOT.*TB* test were 82.9% and 78.6%, and those by IGRA-ELISA were 81.7% and 75.2%, [Table 1](#t0005){ref-type="table"}. The median comparison showed that the *median value in active TB (ATB) group was significantly higher than that in with nonactive TB (NATB) group* for the two IGRAs tests; however, neither of the assays can be applied to diagnose active TB as they cannot differentiate active TB from NATB; see [Fig. 1](#f0005){ref-type="fig"}.Table 1The performance of T-SPOT.TB and IGRA-ELISA for diagnosis ATB.Table 1PerformanceAssays*P* valueT-SPOT.*TB*IGRA-ELISASensitivity:%82.981.70.867Specificity:%78.675.20.023[\*](#tbl1fnStar){ref-type="table-fn"}[^2]Fig. 1The comparison of values between ATB group and NATB group in positive results for (A) T-SPOT.*TB* test and (B) IGRA-ELISA test. ATB was active tuberculosis; and NATB was nonactive tuberculosis.Fig. 1

1.2. Analysis of positive test results {#s0015}
--------------------------------------

The positive results were divided into four groups according with the test values, and except for group 3, the proportion of positives was similarly distributed between the two tests ([Table 2](#t0010){ref-type="table"}). The PPVs of the two tests at different cutoffs for diagnostic ATB were analyzed ([Fig. 2](#f0010){ref-type="fig"}).Table 2The analysis for positive results of T-SPOT.*TB* and IGRA-ELISA tests.Table 2GroupsIGRA-ELISAT-SPOT.*TBP* valueRange: pg/mLProportions(%)Range: SFCsProportions(%)Group 114--10038.066--2039.10.232Group 2100--20018.6220--4022.460.689Group 3200--30024.2940--6019.870.008[\*](#tbl2fnStar){ref-type="table-fn"}Group 4\>30019.03\>6018.570.282[^3]Fig. 2The positive predictive value of T-SPOT.*TB* and IGRA-ELISA test at cutoff 1, cutoff 2, cutoff 3 and cutoff 4. Cutoff 1, 2, 3, 4 for T-SPOT.*TB* were 6, 20, 40 and 60 SFCs; those for IGRA-ELISA were 14, 100, 200 and 300 pg/mL.Fig. 2

1.3. The consistency of the two tests {#s0020}
-------------------------------------

204 patients were tested using both the *T-SPOT.TB and IGRA-ELISA*. The positive, negative, and total coincidence rates between the two tests were 95.5% (84 of 88), 90.5% (105 of 116), and 92.7% (189 of 204), respectively.There was excellent consistency between the two tests with a kappa value of 0.852 (χ2 = 148.64, *p* \< 0.0001). When *84 samples that were positive to both of the two tests* were analyzed, we found that the value change trend of the IGRA-ELISA was consistent with that of T-SPOT.TB test, *and* the two curves intersected at approximately 50 pg/mL (IGRA-ELISA) and 30 SFCs (T-SPOT.TB).

2. Experimental design, materials and methods {#s0025}
=============================================

2.1. Enrolled population {#s0030}
------------------------

A total of 3727 patients with suspected *Mycobacterium tuberculosis* infection at the First Affiliated Hospital of Xi'an Jiaotong University were enrolled. Among them, 204 were tested using both the T-SPOT.TB and IGRA-ELISA, 1794 were tested using the T-SPOT.TB only, and 1729 were tested using the IGRA-ELISA only. The median age was 55 years, the majority of participants (*n*=2100 \[56.3%\]) were men. 244 patients were diagnosed with active TB if at least one of the following conditions were fulfilled: (i) smear-positive for acid-fast bacilli *or TB PCR-positive*, *n* =19, (ii) chest X-ray findings consistent with a radiological diagnosis of PTB, *n*=53, (iii) granulomata or caseous necrosis observed on histopathological examination of biopsy specimens, *n*=45, or (iv) despite the absence of explicit evidence of active TB on microscopy, *TB PCR*, chest X-ray, or histopathology, the clinical symptoms were consistent with active TB and responded to anti-TB treatment (*n*=127). 129 and 115 of the patients underwent the T-SPOT.*TB* and IGRA-ELISA testing, respectively.

2.2. Performing the T-SPOT.TB and IGRA-ELISA test {#s0035}
-------------------------------------------------

Peripheral blood samples from the participants were collected in lithium-heparin-coated tubes. The T-SPOT.TB test (Oxford Immunotec Ltd., Abingdon, UK) was performed within 6 h of obtaining the blood sample. The separation and incubation of peripheral blood mononuclear cells were conducted as previously reported [@bib1]. The IGRA-ELISA (WanTai Biological Pharmacy Enterprise Co, Ltd., Beijing, China) was performed within 2 h of obtaining the blood sample. 1 mL of blood was added to each of 3 heparinized tubes (T, N, and P tube). The tubes were incubated at 37 °C for 20--24 h and were then centrifuged at 3000--5000 rpm for 10 min. The supernatant was used for the ELISA assay, performed using an automated instrument.
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[^2]: Statistically significant association, *P*\<0.05.

[^3]: Statistically significant association, *P*\<0.05.
